In fact, the interest on this protein has increased due to evidences that decreased PON1 activity is related to several non-communicable diseases, such as cancer, obesity, DM, CVD, neurodegenerative diseases, and NAFLD [73,74]. Here, PON1 is linked to metabolic dysfunction-associated steatotic liver disease.